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Objectives: Recovery from pediatric cardiac surgery is affected by ischemia–reperfusion injury, cardiac edema,
and in some cases a low cardiac output syndrome. Although association has been made between the development
of edema and dysfunction, modeling is confounded by intercurrent injurious stimuli that also cause cardiac edema
and dysfunction. We tested whether a true causal relationship exists between edema and cardiac dysfunction.
Methods: We induced either ischemia or edema alone in isolated cardiomyocytes and whole Langendorff-per-
fused hearts. Function was measured as shortening dynamics and developed pressure, respectively.
Results: Ischemic injury impaired function in both cardiomyocytes and whole hearts. Isolated cells showed sig-
nificant reduction in peak shortening and departure and relaxation velocities. Whole hearts displayed severely re-
duced developed pressures. Hyposmotic solution forced cardiomyocytes to swell to 7% greater than their normal
size. No significant effect on shortening was seen. Similarly, Langendorff-perfused hearts were induced to take on
3% more water than control-perfused hearts and 9% more water than nonperfused hearts. This additional water
was associated with mild dysfunction.
Conclusions: We demonstrate the capacity of the heart to tolerate edema greater than that seen in clinical settings
without residual effect. Ischemia results in ongoing contractile dysfunction of both isolated cardiomyocytes and
whole hearts. We conclude that dysfunction resulting from edema in ex vivo cardiac models is mild and suggest
review of the importance given to edema-mediated dysfunction after cardiac surgery.E
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Development of cardiac dysfunction is a significant clinical
concern after cardiac surgery with cardiopulmonary bypass
and myocardial ischemia managed with cooling and preserva-
tion solutions. As many as 20% of pediatric patients undergo-
ing surgical intervention to correct congenital heart defects
experience a clinically significant low cardiac output syn-
drome in the first 6 to 24 hours of their recovery. Potential
sources of myocardial damage that can affect function include
direct myocardial trauma (eg, ventriculotomy), the systemic
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and ischemia–reperfusion injury.1,2 Edema is also commonly
included in this list of potential effectors because it is tempo-
rally associated with development of low cardiac output.3
Various studies have argued that edema is causal in the de-
velopment of cardiac dysfunction.3 Both edema and cardiac
dysfunction have a number of initiators and promoters, mak-
ing a direct causal relationship difficult to prove. Ischemia,4
endothelial damage with capillary leak,5 and hypothermic car-
dioplegia6 are all associated with the development of edema.
However, these injuries are complex and sometimes interre-
lated in their effects. Thus a true causal relationship between
edema and cardiac dysfunction remains to be established. We
have recently examined this in a whole-animal model,7 rein-
forcing the need for in vitro dissection of these pathways.
Several studies using isolated cardiomyocytes6,8,9 and ex
vivo whole hearts10 have been put forward as evidence for
a causal relationship between edema and cardiac dysfunc-
tion. As with surgical models, coexisting factors, including
ischemia and hyperkalemic cardioplegia, complicate inter-
pretation. We aimed to specifically examine the effect of
swelling on the function of isolated cardiomyocytes and
whole hearts by using simple tonicity change to definitively
determine the importance of edema to dysfunction. Ischemic
injury was separately investigated.
MATERIALS AND METHODS
Experiments were approved by the Westmead Hospital Animal Ethics
Committee. Animals received humane care in compliance with the National
Health and Medical Research Council of Australia guidelines.ardiovascular Surgery c Volume 138, Number 1 141
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HEPES ¼ N-2-hydroxyethylpiperazine-
N-2-ethanesulfonic acid
Isolation of Cardiomyocytes
Wistar rats (200–350 g) were anesthetized with inhaled isoflurane. Ster-
notomy was performed, and the heart was excised and immediately placed
in ice-cold Krebs buffer (Sigma, St Louis, Mo). After cannulation, hearts
were perfused at 6 to 8 mL/min, with oxygenated solutions warmed to
37C. Perfusion for 5 minutes with Krebs buffer was followed by 5 minutes
of perfusion with nominally calcium-free Tyrode’s buffer containing 140
mmol/L NaCl, 5.4 mmol/L KCl, 1 mmol/L MgCl2, 5 mmol/L N-2-hydrox-
yethylpiperazine-N-2-ethanesulfonic acid (HEPES), 20 mmol/L taurine,
and 10 mmol/L glucose. Digestion was then achieved by means of perfusion
for 20 minutes with Tyrode’s buffer containing 1 mg/mL collagenase type II
(Worthington Biomedical, Lakewood, NJ), 1 mg/mL hyaluronidase type I
(Sigma), and 175 mmol/L CaCl2. Hearts were removed from the apparatus,
coarsely minced, and subjected to 33 5-minute rounds of digestion at 37C
with gentle mechanical agitation. Cells were filtered through a 180-mm fil-
ter, pelleted by means of gravity, and washed in Tyrode’s buffer containing
increasing amounts of calcium to a final concentration of 1 mmol/L.
Isolated Cardiomyocyte Buffers
Cardiomyocytes were placed in a custom chamber (IonOptix Corp, Mil-
ton, Mass) on an inverted microscope (Coherent Scientific, Hilton, Australia)
and perfused at 1 to 2 mL/min, with buffers warmed inline (Cell MicroCon-
trols, Norfolk, Va) to 25C. Buffers for swelling studies were taken from the
work of Ogura and colleagues11 with some modification and are summarized
in Table E1. The primary buffer was Tyrode’s buffer, containing 140 mmol/
L NaCl, 5.4 mmol/L KCl, 1 mmol/L MgCl2, 5 mmol/L HEPES, 10 mmol/L
glucose, and 1 mmol/L CaCl2, which is referred to as Isotonic (1T). Tyrode’s
buffer in which 35 mmol/L NaCl was replaced with 70 mmol/L sucrose was
referred to as LowNa Isotonic, and Tyrode’s buffer with 35 mmol/L NaCl
removed to make the solution hypotonic was referred to as 0.75T. This de-
gree of tonicity is at the moderate end of previously described models11
and induces cardiomyocyte swelling to a degree that is broadly comparable
with that experienced by infants after cardiopulmonary bypass.12,13 Buffers
for ischemia experiments were taken from Lu and coworkers14 and contained
140 mmol/L NaCl, 5.4 mmol/L KCl, 1 mmol/L MgCl2, 5 mmol/L HEPES, 1
mmol/L CaCl2, and 2.5 mmol/L Na-lactate. Isotonic, LowNa Isotonic, and
0.75T buffers were adjusted to pH 7.4 and oxygenated, whereas the ischemic
buffer was adjusted to pH 6.8 and bubbled with 100% N2.
Isolated Cardiomyocyte Functional Analysis
Cardiomyocytes were loaded with Fura-2-AM (Invitrogen, Carlsbad,
Calif) by means of incubation in a 5 mmol/L solution at room temperature
for 10 minutes, followed by washing. Intracellular calcium was measured
by exciting cardiomyocytes alternately at 340 and 380 nm and reading emis-
sion at 505 nm. Function was measured by using video-based detection and
calculation of sarcomere length (IonOptix, Milton, Mass). Unloaded cells
were paced (MyoPacer, IonOptix) to contract at a frequency of 1 Hz while
sarcomere length and Fura-2 transients were recorded. A minimum of 10
transients were averaged from each cell and treatment. Measures of sarco-
mere length and intracellular calcium analyzed included resting (diastolic)
and peak (systolic) values, maximum departure and return velocities, the
time of transient onset, peak time, and the constant tau describing calcium
removal. Cells were excluded from analysis if they displayed membrane
blebs, resting sarcomere lengths of less than 1.6 mm, frequent spontaneous
contractions without stimulation, or less than 5% shortening.142 The Journal of Thoracic and Cardiovascular SurIsolated Cardiomyocyte Experimental Protocols
Cells were separated into 3 treatment groups. The numbers of cardiomyo-
cytes per group ranged from 9 to 21 and were derived from 4 to 6 individual
rats. Each treatment group consisted of a baseline, test, and recovery phase,
with functional parameters measured at the end of each phase. For swelling
studies, cells were first perfused with LowNa Isotonic buffer, followed by 8
minutes in 0.75T buffer and recovery in LowNa Isotonic buffer for 8 min-
utes. Control cells were perfused continuously with LowNa Isotonic buffer,
and recordings were made at times equivalent with the test group. In ischemic
experiments cells were perfused with Isotonic buffer followed by 10 minutes
in ischemic buffer. Recovery was measured at 3 and 10 minutes of reperfu-
sion in either LowNa Isotonic buffer or 0.75T buffer.
Cell area was calculated for all cells by using images captured at the end of
each treatment period (baseline, test, and recovery) of cardiomyocytes in dias-
tole. Cell borders were manually traced, and area in square micrometers was
calculated with ImageJ software (National Institutes of Health, Bethesda, Md).
Whole-Heart Functional Analysis
Hearts were removed following the same procedure as for preparation of
isolated cardiomyocytes, cannulated, and perfused through a Langendorff
apparatus (Radnoti Glass Technology, Inc, Monrovia, Calif) at 80 to 90
mm Hg of pressure with carbogen (95% O2 and 5% CO2) gassed buffers
warmed to 37C, as previously described.15 The standard Krebs buffer con-
sisted of 118 mmol/L NaCl, 25 mmol/L NaHCO3, 4.8 mmol/L KCl, 1.2
mmol/L KH2PO4, 1.2 mmol/L MgSO4, 1.2 mmol/L CaCl2, and glucose.
11
The left atrial appendage was removed, and a drain was inserted to prevent
fluid build-up in the left ventricle. A latex balloon was then placed in the left
ventricle, and diastolic pressure was set to 5 mm Hg. Measurements of left
ventricular pressure (systolic and diastolic) and heart rate were collected on-
line in real time (PowerLab; ADInstruments, Inc, Colorado Springs, Colo).
Individual hearts were only included if the intrinsic heart rate was greater
than 200 beats/min and achieved greater than 100 mm Hg systolic pressure
within 20 minutes of perfusion.
Whole-Heart Experimental Protocols
Control nonperfused hearts were removed as for cannulated hearts but
immediately processed without perfusion. For all other treatment groups,
hearts were first stabilized for 20 minutes. Two main experimental designs
were used to investigate the effect of (1) osmotic or oncotic pressure
changes and (2) ischemia. Mild osmotic and oncotic changes were produced
according to the methodology of Kellen and Bassingthwaighte.16 Hearts
were perfused with Krebs buffer plus an additional infusion of 15 mmol/
L NaCl, 30 mmol/L sucrose, or 0.5% dextran. Severe hypotonicity was
achieved by removing 35 mmol/L NaCl from the Krebs buffer. This pro-
duced a 0.75T hypotonic equivalent to match that used in cardiomyocyte
experiments. Infusion of 70 mmol/L sucrose to the 0.75T Krebs buffer
produced isosmotic Krebs buffer (see Table E1). For ischemia experiments,
hearts were perfused with Krebs buffer. Baseline function was measured for
20 minutes, followed by 30 minutes of zero-flow ischemia and 50 minutes
of reperfusion. These were matched by a perfusion control group, which
was produced by maintaining perfusion for 100 minutes. At the end of per-
fusion, all hearts were weighed and dried before reweighing to determine the
percentage water by using the following formula:
ðWeight ½WetWeight ½Dry=Weight½WetÞ3100:
Statistical Analysis
Results are expressed as means standard error of the mean. All statistical
analyses were performed with SPSS version 15.0 (SPSS, Inc, Chicago, Ill).
For isolated myocyte and heart water analyses, the Kruskal-Wallis test, fol-
lowed by the Mann-Whitney U test, was used to compare treatment and con-
trol groups. Within-group comparison of baseline, test, and recovery values
used the Friedman test, followed by the Wilcoxon signed-rank test. In isolatedgery c July 2009
Butler et al Evolving Technology/Basic Sciencecardiomyocyte analyses, significance was only accepted if both within-group
and between-group significance from the isotonic control group were shown
to account for variability in data and time-dependent changes in cardiomyo-
cyte function. Sequential time-based measurements of function obtained
from Langendorff experiments were analyzed with analysis of variance for re-
peated measures followed by least significant difference post-hoc testing.
RESULTS
Effect of Cardiomyocyte Swelling on Function
Mean cardiomyocyte area after test and recovery perfu-
sion were measured. Cardiomyocyte cell size was not signif-
icantly changed during continuous perfusion in isotonic
buffer. Hypotonic exposure resulted in swelling to 7.0%
greater than baseline (P< .001). Reperfusion with isotonicThe Journal of Thoracic and Cbuffer resulted in a return of cardiomyocyte size to just be-
low the baseline value (P< .05).
Transient data for all isolated cardiomyocyte treatment
groups can be found in Table E2. Calcium transients of car-
diomyocytes were altered by swelling. Although the resting
level of intracellular calcium was unchanged (Figure 1, A),
peak intracellular calcium levels were lower in swollen
cardiomyocytes relative to baseline (P< .001) and isotonic
control (P ¼ .001) values (Figure 1, B). Other aspects of
intracellular calcium dynamics were unchanged, including
calcium clearance (Figure 1, C).
The only statistically significant effect of swelling on car-
diomyocyte shortening was a small decrease in the time toE
T
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SFIGURE 1. Mean transient data are shown for intracellular calcium (left panel) and sarcomere shortening (right panel) of isolated cardiomyocytes. Mea-
surements were made at baseline (black bars), test (hatched bars), and recovery (gray bars). The isotonic control group was produced by continuous perfusion
of cells with isotonic buffer and used for statistical comparison with the hypotonic and ischemic test groups. A, Diastolic intracellular calcium values are
significantly increased in ischemic cells (***P< .001 isotonic vs ischemic; **P< .01 basal vs ischemic) and returned to the baseline level with isotonic
reperfusion. B, Peak intracellular calcium values are reduced in swollen cardiomyocytes of the hypotonic group (***P< .001 isotonic vs hypotonic;
***P<.001 basal vs hypotonic). C, The calcium clearance constant tau is significantly increased during ischemic exposure (***P<.001 isotonic vs ischemic;
**P<.01 basal vs ischemic). D, Diastolic sarcomere length is not significantly altered by hypotonic or ischemic treatment. E, Peak shortening is significantly
reduced by ischemia (*P<.05 isotonic vs ischemic; ***P<.001 basal vs ischemic). F, Maximum velocity of shortening is significantly reduced by ischemia
(*P< .05 isotonic vs ischemic; ***P< .001 basal vs ischemic). Data are presented as means  standard error of the mean.ardiovascular Surgery c Volume 138, Number 1 143
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vs isotonic control). Resting sarcomere length (Figure 1, D)
was unchanged by hypotonic challenge. Despite the reduced
peak calcium value seen in swollen cardiomyocytes, peak
shortening was not significantly different from that seen in
isotonic control specimens (Figure 1, E).
Effect of Cardiomyocyte Ischemia on Function
Ischemia resulted in an average 2.3% increase in cardio-
myocyte volume relative to baseline values (P< .01), with
return to normal size after isotonic recovery. When ischemic
cells were recovered in 0.75T buffer, area increased further
to 5.8% greater than the baseline value. This was statisti-
cally significant when compared with both baseline (P<
.01) and ischemic (P< .01) cardiomyocyte size.
Cardiomyocytes subjected to ischemia displayed in-
creased intracellular calcium in diastole compared with
within-group baseline values (P<.01) and the isotonic con-
trol group (P ¼ .001; Figure 1, A), which resolved with
isotonic recovery. Peak calcium values were unchanged
(Figure 1, B). Slower calcium clearance was seen in ische-
mic cells as an increase in tau compared with the baseline
value (P< .01) and as a relative change compared with
that seen in the isotonic control group (P< .001; Figure 1,
C).
Ischemic insult profoundly affected cardiomyocyte short-
ening. Ischemic cells displayed a small increase in diastolic
sarcomere length (P<.01; Figure 1,D) and reduced velocity
of relengthening (P< .01) compared with their baseline
value that was not significantly different from that of the iso-
tonic control specimens. Peak shortening was greatly re-
duced in ischemic cells (P ¼ .001, test vs baseline; P<
.05, ischemic vs isotonic control; Figure 1, E). Maximum
shortening velocity was also impaired (P ¼ .001, test vs
baseline; P< .05, ischemic vs isotonic control; Figure 1,
F). A small reduction in the time to peak shortening
of ischemic cardiomyocytes (P < .01, test vs baseline;
P< .01, ischemic vs isotonic control) returned to baseline
with isotonic recovery.
Langendorff Perfusion and Heart Water Content
Langendorff-perfused hearts became swollen in compari-
son with nonperfused hearts, taking on 6.2% more water.
For the group sizes used, water content was not measurably
affected by small increases in osmotic or oncotic balance in-
duced by infusion of 15 mmol/L NaCl, 30 mmol/L sucrose,
or 0.5% dextran when compared with control Krebs-
perfused hearts (data not shown). Water loading was also un-
changed at the end of ischemia and reperfusion compared
with that seen in control-perfused hearts (data not shown).
Hyposmotic perfusion with 0.75T Krebs buffer induced
swelling of Langendorff-perfused hearts. For comparison
with later functional data, water content of a subset of hearts
(n ¼ 4 per group) was compared at the end of each perfusion144 The Journal of Thoracic and Cardiovascular Suphase: after 20 minutes of isosmotic Krebs perfusion, after
hypotonic Krebs perfusion, and after reperfusion in isos-
motic Krebs buffer. Hearts perfused with 0.75T hyposmotic
Krebs buffer took on 3.3% more water than hearts perfused
with isosmotic Krebs buffer (P< .05). This swelling re-
solved to baseline values during isosmotic recovery.
Langendorff Perfusion and Functional Analysis
Systolic and diastolic pressures of the main experimental
groups are shown in Figure 2. Diastolic pressure was unaf-
fected by continuous perfusion in isosmotic Krebs buffer,
whereas a nonsignificant trend toward decreasing systolic
pressure was seen over time (data not shown). The func-
tional effect of small osmotic or oncotic increases was mea-
sured with infusion of 15 mmol/L NaCl, 30 mmol/L sucrose,
or 0.5% dextran. Systolic and diastolic pressures were not
statistically altered by infusion with NaCl (Figure 2, A) or
sucrose. Diastolic pressure in the presence of 0.5% dextran
infusion was significantly higher than without this oncotic
agent (P< .01; Figure 2, B). Systolic pressure was unaf-
fected (Figure 2, B).
Diastolic pressure was mildly but significantly increased
when the perfusate was changed from isosmotic to 0.75T
hyposmotic (P< .001) and returned to baseline during sub-
sequent perfusion in isosmotic Krebs buffer (Figure 2, C).
Systolic pressure was stably reduced during 0.75T hypo-
smotic perfusion (P< .01) and also recovered to control
values with return to isosmotic perfusion (Figure 2, C).
Injury induced by 30 minutes of room-temperature global
ischemia produced diastolic dysfunction, which was seen as
an increase in diastolic pressure (P< .05, reperfusion vs
baseline; Figure 2, D). Systolic pressure was decreased in
the reperfusion phase compared with the baseline value
(P< .05, reperfusion vs baseline; Figure 2, D) but was not
statistically significant from that seen in control-perfused
hearts (data not shown).
DISCUSSION
The primary aim of this study was to investigate the effect
of edema on cardiomyocyte and whole-heart function. We
used models to analyze the effect of edema without other in-
sults that confound previous studies in this area. Separately,
we subjected isolated cardiomyocytes and whole hearts to
ischemic injury. Ischemia is a necessary aspect of cardiac
surgery involving cardiopulmonary bypass, and our investi-
gations are performed with a long-term view toward improv-
ing clinical treatment in this area.
Edema and Cardiac Function
Our data show a temporal correlation that supports a mod-
est but causal link between edema and dysfunction. Al-
though we provide support for this relationship, it is not as
striking as has been suggested by others. Work by Mehlhorn
and colleagues3 using surgical models has shown a 3%rgery c July 2009
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Butler et al Evolving Technology/Basic ScienceFIGURE 2. Mean systolic and diastolic pressures throughout perfusion. For experiments using osmotic/oncotic change by infusion (A–C) the experiment
was 60 minutes total, made up of 20 minutes with infusion, 20 minutes without infusion, and 20 minutes with infusion. A, 15 mmol/L NaCl. No significant
differences were seen. B, 0.5% dextran. Diastolic pressure decreased when dextran infusion was stopped (**P< .01). C, 0.75T hyposmotic Krebs buffer
made isosmotic with 70 mmol/L sucrose infusion. Systolic (*P<.05) and diastolic (*P<.05) pressures of swollen hearts in the 0.75T hyposmotic phase were
significantly different from both baseline and recovery isosmotic values. D, For ischemic experiments, 10 minutes of baseline measurement is followed by 30
minutes of no-flow ischemia in which systolic pressure decreased to near zero and 50 minutes of reperfusion. Systolic (*P< .05) and diastolic (P< .05)
pressures in the reperfusion phase are significantly different from baseline. Note that the time course and scale in panels C and D are different and should
not be directly compared. Shown are means  standard error of the mean.increase in heart water content to be associated with as much
as a 50% decrease in cardiac function. Langendorff-based
investigation has suggested a 5% increase in cardiac water
to be sufficient to inhibit developed pressure by 50%.17
Our data show that small differences in osmotic or oncotic
pressure, which are known to alter water content,16 were tol-
erated by Langendorff-perfused hearts, with no deleterious
effect on function. Swelling of 3.3% greater than that seen
with control-perfused hearts was associated with a reduction
in developed pressure of 9% that resolved completely on
return to baseline water content. Other investigators have
suggested that small increases in water content might not
affect cardiac function,18 and we conclude that even
moderate increases are well tolerated.
In the clinical setting cardiac edema after cardiopulmo-
nary bypass is largely thought to be caused by interstitial wa-
ter accumulation. The effect of interstitial edema on cardiac
performance was not examined because of the technical con-The Journal of Thoracic and Cstraints of our ex vivo models. Tissue water increases during
early equilibration of Langendorff perfusion,19 which is
likely to be interstitial water gain. Reliable functional mea-
surements do not begin until after equilibration, and as
such, both the control and treatment groups are similarly
swollen initially. Hyposmotic perfusion after equilibration
results in increased intracellular water.20 As such, our Lan-
gendorff model tests the functional effect of intracellular
swelling.
Intracellular edema induced in whole hearts resulted in re-
duced developed pressure, as has been seen by others,21 al-
though isolated cardiomyocyte shortening was unaffected
by swelling. The functional deficit seen in swollen Langen-
dorff-perfused hearts might be explained by impaired force
development; swelling of isolated cardiomyocytes was
associated with reduced peak intracellular calcium values,
and this is also likely to occur in whole hearts. Regardless
of the cause of the dysfunction, our data suggest thatardiovascular Surgery c Volume 138, Number 1 145
E
T
/B
S
Evolving Technology/Basic Science Butler et alintracellular water must be investigated in a whole-organ
setting to provide clinically useful information.
Ischemia and Cardiac Function
Modeling ischemia in vitro is necessarily different from in
vivo cardiac ischemia induced in the context of cardiopul-
monary bypass. In particular, stopping the heart with cardi-
oplegia, the addition of various substrates, and cooling
during surgical intervention aims to minimize ischemic in-
jury. We modeled ischemia in isolated cardiomyocytes
with a buffer that mimics the ischemic milieu, including
the presence of lactate, but maintained continuous cardio-
myocyte contraction. The whole-heart Langendorff model
produced global ischemia also with continuous contraction.
We recognize that these models are fundamentally different
from the surgical situation. However, they allow us to clarify
the specific effect of ischemia without confounders, such as
hypothermia or cardioplegia. Furthermore, comparison can
be made between our results and those of other re-
searchers,14,22,23 validating the model and thus comparison
of edematous and ischemic effects.
Cardiac edema and dysfunction have been linked in the
context of cardioplegia studies. In some instances dysfunc-
tion has been attributed to edema without controlling for
the effects of hypothermia and hyperkalemia.6 Mild hypo-
thermia in anesthetized dogs induces diastolic dysfunc-
tion.24 Support for hyperkalemia as a primary effector is
provided by demonstration of improved systolic function
of isolated hearts after ischemia with reduced-potassium car-
dioplegia10 and normokalemic cardioplegia25 in comparison
with a standard hyperkalemic cardioplegia. The potential
additive effect of multiple injuries in these models is high-
lighted, including the finding that cardioplegia itself induces
edema. We have examined these issues in a separate model
of infant cardiac surgery.7
Global ischemic injury in Langendorff experiments in-
duced ongoing functional impairment in the recovery phase.
Ischemic injury in isolated cardiomyocytes aimed to repli-
cate the injury of the whole-heart model as closely as possi-
ble. The lactate concentration in particular was chosen to
induce functional impairment but not cell death and is within
the physiologic range reported during ischemia in vivo.4,26
The severity of injury induced was broadly similar in the 2
models. In the recovery phase after ischemia, peak shorten-
ing of isolated cardiomyocytes recovered to 84% of control
values, and Langendorff-perfused hearts generated devel-
oped pressures that were 75% of control values.
Tissue osmolarity is expected to increase during cardiac is-
chemia, resulting in an osmotic imbalance with reperfusion
that induces swelling. Although we saw no difference between
ischemic and control hearts in water content, others have
shown edema in the reperfusion phase after global ischemia.23
Osmotic fragility resulting from ischemic injury might con-
tribute to postischemic swelling and functional decline. How-146 The Journal of Thoracic and Cardiovascular Surever, our comparison of ischemic cardiomyocyte function and
calcium dynamics when recovered in either isotonic or 0.75T
hypotonic buffer revealed no differences (data not shown).
Using the Langendorff model, others have demonstrated is-
chemia-induced membrane permeability that protects cardio-
myocytes from swelling in the reperfusion phase.20 Further
work is needed to determine whether edema might act as a sig-
nificant cocontributor to ischemia–reperfusion injury.
CONCLUSIONS
Ischemia, as expected, directly affects the cardiomyocyte.
Sustained functional deficits are seen in both isolated cells
and whole hearts injured by ischemia. Reduced systolic
pressures in whole edematous hearts might be related to
the reduced peak calcium values seen in swollen cardiomyo-
cytes. The functional inhibition is transient and does not
extend beyond the phase of swelling.
Reducing the morbidity that can result from pediatric car-
diac surgery depends on better myocardial management. A
clear understanding of the causes of myocardial dysfunction
is fundamental to this aim. When studied in isolation, our
data argue against edema as a major contributor to reduced
cardiac performance. Edema might exacerbate dysfunction
in the context of insults such as ischemic damage but
further modeling is necessary to determine the extent to
which this contributes.
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TABLE E1. Primary buffer components for isolated cardiomyocytes and Langendorff-perfused hearts
Osmolarity (mOsm approximation) NaCl (mmol/L) Sucrose (mmol/L) Lactate (mmol/L)
Ogura Tyrode’s buffer: isolated cardiomyocytes – –
Isotonic (pH 7.4) 320 140 – –
0.75T Hypotonic (pH 7.4) 240 105 – –
LowNa Isotonic (pH 7.4) 320 105 70 –
Ischemic (pH 6.8) 320 140 – 2.5
Krebs buffer: Langendorff-perfused hearts
Isosmotic Krebs buffer 330 118 – –
0.75T Hyposmotic Krebs buffer 260 83 – –
LowNa Isosmotic Krebs buffer 330 83 70 –
TABLE E2. Shortening and Fura-2 transients for isolated cardiomyocytes
Shortening transient Calcium transient
Group A Group B Group C Group D Group A Group B Group C Group D
Resting Baseline 1.727  0.015 1.763  0.012 1.742  0.017 1.749  0.017 1.213  0.064 1.364  0.088 1.577  0.100 1.543  0.102
Test 1.721  0.016 1.774  0.013 1.776  0.019 1.771  0.018 1.206  0.070 1.328  0.099 1.798  0.148y 1.791  0.147
Recovery 1.721  0.015 1.769  0.014 1.743  0.018 1.738  0.020 1.233  0.073 1.380  0.103 1.581  0.121 1.714  0.158
Dep v
(U/s)
Baseline 2.532  0.350 3.012  0.193 2.617  0.292 2.470  0.353 30.723  2.546 28.954  3.301 28.282  1.438 31.498  2.113
Test 2.261  0.314 2.707  0.234 1.302  0.250* 1.385  0.229 28.788  3.122 23.743  2.761 23.156  1.340 23.990  3.042
Recovery 2.272  0.329 2.190  0.141 1.808  0.256 2.234  0.274 26.833  3.366 24.914  2.823 23.140  2.118 21.522  2.171
%Peak h/
peak h
Baseline 10.071  1.130 11.107  0.550 9.571  0.765 10.230  0.927 1.376  0.110 1.291  0.145 1.289  0.071 1.461  0.079
Test 8.983  0.960 9.572  0.500 4.852  0.848* 5.898  0.831 1.283  0.116 1.035  0.119z 1.076  0.073 1.210  0.120
Recovery 8.915  0.981 8.738  0.408 7.239  0.834 9.259  0.943 1.245  0.133 1.129  0.117 1.080  0.069 1.031  0.063
Peak t (s) Baseline 0.173  0.006 0.161  0.007 0.151  0.009 0.169  0.009 0.085  0.004 0.091  0.006 0.085  0.007 0.090  0.003
Test 0.164  0.006 0.145  0.009* 0.125  0.008 0.146  0.009 0.085  0.004 0.080  0.003 0.083  0.007 0.108  0.012
Recovery 0.164  0.007 0.150  0.008 0.150  0.007 0.162  0.010 0.090  0.004 0.096  0.008 0.092  0.006 0.095  0.012
Ret v
(U/s)
Baseline 1.673  0.223 2.472  0.224 2.120  0.242 2.217  0.398 6.494  0.765 6.228  0.904 6.612  0.604 6.682  0.269
Test 1.595  0.222 2.201  0.213 1.190  0.257 1.161  0.179 5.555  0.638 5.287  0.823 5.129  0.254 4.995  0.525
Recovery 1.785  0.328 1.886  0.144 1.527  0.249 2.080  0.324 5.845  0.968 5.788  0.741 5.625  0.475 5.599  0.657
Tau Baseline 0.186  0.009 0.184  0.009 0.175  0.011 0.184  0.007
Test 0.187  0.010 0.188  0.010 0.200  0.013y 0.215  0.012
Recovery 0.184  0.010 0.183  0.008 0.181  0.013 0.182  0.008
Shortening transients measure sarcomere length in micrometers. Calcium transients are measured as the 340/380 nm ratio of Fura-2. Resting, Diastolic value; Dep v, departure
velocity;%Peak h (shown for shortening transients), systolic peak value as a percentage of diastolic value; peak h (shown for calcium transients), systolic peak value minus diastolic
value; Peak t, time of peak; Ret v, maximum relaxation velocity; tau, diastolic single exponential constant.Group A, Isotonic control; Group B, 0.75T hypotonic; Group C, ischemic
(isotonic recovery); Group D, ischemic (hypotonic recovery). *P< .05, yP< .01, and zP< .001.
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